Journal profile · Medicine-Medicine (miscellaneous)
Emerging Trends in Drugs Addictions and Health
ISSN 2667-1182 · Elsevier · United Kingdom
Emerging Trends in Drugs Addictions and Health: fully open access; APC about USD 2,000; review about 160 days (submission to acceptance, publisher); 97 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Emerging Trends in Drugs Addictions and Health is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Forensic Toxicology and Drug Analysis, Substance Abuse Treatment and Outcomes and Opioid Use Disorder Treatment, together about 47.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS (ISSED)Emerging Trends in Drugs, Addictions, and Health is an international Journal devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addictions and associated health phenomena. The Journal has a multidisciplinary nature and aims to bring together studies which are relevant for heterogeneous authors and readers. Manuscripts related to:clinical practicedoping science experimental psychologyforensic medicinegeneticshealth economicshealth policyhealth psychology internal medicinemental healthmolecular biologyneurosciencepharmacologypublic healthsport and exercise sciencetreatment trialsare encouraged for submission as far as they deal with the ever-changing world of addictions and psychoactive substances. The overall purpose of the Journal is to contribute to improve the knowledge on the field with a comprehensive biological, psychological, clinical, and social perspective.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (miscellaneous)
Editor-in-chief Ornella CorazzaPublisher website
Editorial board by country: none in mainland China; most named Italy 10, United Kingdom 8, United States 6, Spain 2, Netherlands 2 (38 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics23.7%
- Substance Abuse Treatment and OutcomesMedicine15.8%
- Opioid Use Disorder TreatmentMedicine8%
- Psychedelics and Drug StudiesPsychology5.6%
- HIV, Drug Use, Sexual RiskMedicine4.6%
- Doping in SportsSocial Sciences4.4%
- Analytical Methods in PharmaceuticalsChemistry4.1%
- Poisoning and overdose treatmentsMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Medicine (miscellaneous) | Q2 | 212/466 | — |
| Clinical Psychology | Q2 | 149/314 | — |
| Psychiatry and Mental Health | Q3 | 318/580 | — |
| Pharmacology | Q3 | 217/328 | — |
| Drug Discovery | Q3 | 118/161 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.8LetPub ·
- CiteScore (publisher)
- 2.8Publisher website ·
- SJR 2026-06
- 0.47LetPub ·
- SNIP 2026-06
- 0.54LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 23OpenAlex ·
- 2-year mean citedness
- 1.03OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 279 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 21 | 216 |
| 2025 | 97 | 97 | 220 |
| 2024 | 103 | 103 | 142 |
| 2023 | 16 | 16 | 95 |
| 2022 | 14 | 14 | 52 |
| 2021 | 27 | 27 | 22 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
160 dayssubmission to acceptance · community reports about 15 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to acceptance
- 160 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 23 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,000 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,000 / EUR 1,870 / GBP 1,600 / JPY 248,060 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 2,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Manuscript length
- ≤ 10,000 words
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted8, with length limits
- case reportThe journal encourages the submission of the following types of manuscript: Review: These are usually between 4,000 and 8,000 words (maximum), and seek to revie…main text ≤ 2,000 words
- editorialThe journal encourages the submission of the following types of manuscript: Review: These are usually between 4,000 and 8,000 words (maximum), and seek to revie…main text ≤ 2,000 words
- letterThe journal encourages the submission of the following types of manuscript: Review: These are usually between 4,000 and 8,000 words (maximum), and seek to revie…Length not stated
- opinionThe journal encourages the submission of the following types of manuscript: Review: These are usually between 4,000 and 8,000 words (maximum), and seek to revie…main text ≤ 2,500 words
- original articleThe journal encourages the submission of the following types of manuscript: Review: These are usually between 4,000 and 8,000 words (maximum), and seek to revie…main text ≤ 5,000 words
- original researchThe journal encourages the submission of the following types of manuscript: Review: These are usually between 4,000 and 8,000 words (maximum), and seek to revie…Length not stated
- reviewThe journal encourages the submission of the following types of manuscript: Review: These are usually between 4,000 and 8,000 words (maximum), and seek to revie…main text ≤ 8,000 words
- systematic reviewThe journal encourages the submission of the following types of manuscript: Review: These are usually between 4,000 and 8,000 words (maximum), and seek to revie…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Abstract must not exceed 250 words Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Data availability
Data statement encouraged Model summary
To foster transparency, you are encouraged to state the availability of any data at submission.
Source ↗Publisher website ·- Publication ethics
Follow Elsevier's Publishing Ethics Policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed per Elsevier policy Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2667-1182
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Emerging Trends in Drugs Addictions and Health
How long does peer review take at Emerging Trends in Drugs Addictions and Health?
The publisher reports about 160 days (submission to acceptance); authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Emerging Trends in Drugs Addictions and Health?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Manuscript length: ≤ 10,000 words; Reference style: Author–date; First submission: Free format: the journal's layout is not required; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Emerging Trends in Drugs Addictions and Health based?
Of the 38 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (10), United Kingdom (8) and United States (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Emerging Trends in Drugs Addictions and Health?
According to LetPub and DOAJ records, Emerging Trends in Drugs Addictions and Health is indexed in Scopus and DOAJ.
Is Emerging Trends in Drugs Addictions and Health open access, and what is the APC?
Emerging Trends in Drugs Addictions and Health is a fully open-access journal. APC about USD 2,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .